Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-018734

Chief Scientific Officer sold 2,004 shares at $1.83 ($3,667)

  • Chief Scientific Officer acquired 5,647 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Georgantas Robert William III · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-09 Exercise or conversion : show line 1 in the form +5,647 20,287 D
2022-05-10 Sale : show line 2 in the form −2,004 $1.83 $3,667 18,283 D
Open-market sales · 2,004 sh · avg $1.83 · $3,667

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-05-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,971 1,971 29,566 D
2022-05-09 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,676 3,676 18,377 D
Loading xslF345X03/form4.xml…